KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Receivables (2016 - 2025)

Labcorp Holdings (LH) has disclosed Receivables for 17 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 7.81% to $2.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 7.81% year-over-year, with the annual reading at $2.3 billion for FY2025, 7.81% up from the prior year.
  • Receivables hit $2.3 billion in Q4 2025 for Labcorp Holdings, roughly flat from $2.3 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $3.1 billion in Q3 2021 to a low of $1.3 billion in Q4 2022.
  • Historically, Receivables has averaged $2.4 billion across 5 years, with a median of $2.3 billion in 2025.
  • Biggest five-year swings in Receivables: crashed 40.13% in 2021 and later surged 66.74% in 2023.
  • Year by year, Receivables stood at $1.8 billion in 2021, then crashed by 30.3% to $1.3 billion in 2022, then soared by 66.74% to $2.1 billion in 2023, then fell by 0.08% to $2.1 billion in 2024, then grew by 7.81% to $2.3 billion in 2025.
  • Business Quant data shows Receivables for LH at $2.3 billion in Q4 2025, $2.3 billion in Q3 2025, and $2.3 billion in Q2 2025.